Clinical Trials Browser

OTHER × Interventional × Hemostatic Disorders × Clear all

NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Phase NA Recruiting

Agnosia, Hemostatic Disorders

NCT03826043 2025-09-30

THEO

Phase NA Completed

Neoplasms, Thrombosis, Hemostatic Disorders

NCT05634005 2025-03-06

Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence

Phase NA Completed

Classical hematologyLymphoid

Afibrinogenemia, Anemia, Lymphoma, Follicular, Thrombocytopenia, Hemostatic Disorders

NCT06644443 2024-10-16

BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma

Phase 1/2 Recruiting

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT03806556 2021-09-20

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

Phase 1/2 Terminated

11 enrolled 15 charts

Classical hematology

Neoplasms, Thrombocytopenia, Hemostatic Disorders

NCT03993977 2020-12-16

ROTEM-SUR

Phase NA Withdrawn

Neoplasms, Blood Loss, Surgical, Hemostatic Disorders

NCT03570281 2018-06-26

ENCHASE

Phase 2/3 Unknown

Hemostatic Disorders